Clinical Trial Update: Efficacy of Botulinum Toxin Type A for Acute Acquired Comitant Esotropia: An Age-Stratified Two-Year Follow-Up Study [NA]

View source ↗

Summary

A clinical trial update reports the two-year, age-stratified efficacy of botulinum toxin type A for treating acute acquired comitant esotropia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Comitant Esotropia

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Acute Acquired Comitant Esotropia | NA | Status: COMPLETED